NA Selank Amidate

NA Selank Amidate

NA Selank Amidate

NA Selank Amidate exhibits improved molecular stability and in vivo pharmacokinetic profile through a double-modification strategy of N-terminal acetylation and C-terminal amidation based on the original structure of Selank.

 

SKU: 198884 Category:
Govera rudo rwako

NA Selank Amidate exhibits improved molecular stability and in vivo pharmacokinetic profile through a double-modification strategy of N-terminal acetylation and C-terminal amidation based on the original structure of Selank.

This results in an increased half-life, enhanced ropa-uropi chipingamupinyi penetration efficiency, and prolonged bioactivity in both molecular and animal models.

Uyezve, NA Selank Amidate exhibits potent immunomodulation and anti-stress activity.

Kutevedzana

ac-thr-lys-pro-arg-pro-gly-pro-nh2

Nhamba yeCAS

/

Molecular Formula

C35H60N12O9

Molecular Weight

792.94

Research Of NA Selank Amidate

1.Retained and Enhanced Efficacy

Efficacy-wise,NA Selank Amidate retains all of the characteristics of Selank, regulating gamma-aminobutyric acid (GABA) neurotransmission in the brain while also modulating the dopaminergic uye serotonergic systems to deliver outstanding anxiolytic uye antidepressant migumisiro.

It also shows better efficacy than Selank in enhancing cognitive and neuroprotective functions, producing pronounced positive effects on learning, memory, and attention.

2.Anxiolytic and Mood-Stabilizing Effects

In a concentration-dependent and subtype-selective manner, NA Selank Amidate allosterically modulates the GABA-A receptor by potentiating the binding efficacy of GABA to its receptor or enhancing chloride ion channel opening efficiency.

This significantly increases the inhibitory tone in key brain circuits, producing marked anxiolytic effects.

Uyezve, the side effects of this anxiolytic action are significantly milder than those of conventional anxiolytic drugs, making NA Selank Amidate a more attractive mood-stabilizing compound.

3.Cognitive Enhancement and Neuroprotection

NA Selank Amidate directly activates BDNF gene transcription by inducing phosphorylation of the promoter-located CREB transcription factor and acetylation of histone H3, increasing BDNF mRNA levels 3.2-fold in hippocampal dentate gyrus granule cells and prefrontal cortical pyramidal neurons and protein secretion 2.8-fold within 24 maawa.

This activates the TrkB receptor signaling pathway downstream, inducing the Ras-MAPK and PI3K-Akt cascade to increase dendritic musana density by 39%, upregulate synaptophysin expression by 45%, and restore LTP amplitude to baseline.

This successfully prevents stress-induced hippocampal neuronal injury and cognitive decline, demonstrating distinct neuroprotective properties.

4.Immunomodulatory and Anti-Stress Effects

NA Selank Amidate is a competitive inhibitor of enkephalin-degrading enzyme, protecting endogenous opioid peptides from hydrolysis and thereby elevating their levels, while it inhibits LPS (lipopolysaccharide)-induced expression of pro-inflammatory cytokines kusanganisira IL-6 uye TNF-α by 40–60% in astrocytes.

NA Selank Amidate also represses NF-κB nuclear translocation by interfering with the recruitment of MyD88 adaptor protein, providing protective regulation in the neuroinflammatory microenvironment.

COA

HPLC

MS

(1) Tinoda, C. R.; Chena, C. M. Sedative-Hypnotic Agents Inobata Gamma-Aminobutyric Acid Receptors: Tarisa paFlunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, uye Selank. J Clin Pharmacol 2021, 61 Suppl 2, S114-S128. DOI: 10.1002/jcph.1922 From NLM M

(2) Murombo chinhu, A.; Kolomin, T.; Andreeva, L.; Bondarenko, E.; Myasoedov, N.; Slominsky, P.; Shadrina, M. Peptide Selank Inovandudza Mhedzisiro yeDiazepam muKuderedza Kuzvidya Mwoyo mune Isingafungidzirwe Chisingaperi Chinyoro Stress Mamiriro mumakonzo.. Behav Neurol 2017, 2017, 50910

(3) Pin, L. G.; Nadorova, A. V.; Antipova, T. A.; Kruglov, S. V.; Kudrin, V. S.; Durnev, A. D. Selank, Peptide Analogue yeTuftsin, Dzivirira Kubva paEthanol-Induced Memory Impairment neKudzora zveBDNF Zvemukati muHippocampus uye Prefrontal Cortex.

(4) Pin, L. G.; Nadorova, A. V.; Seredenin, S. B. Selank Inhibits Ethanol-Induced Hyperlocomotion uye Manifestation of Behavioral Sensitization muDBA/2 Mice.. Bull Exp Biol Med 2016, 162 (1), 56-59. DOI: 10.1007/s10517-016-3544-6 From NLM Medline.

(5) Mutengo, N. V.; Sokolov, O.; Gabaeva, M. V.; Grivennikov, I. A.; Andreeva, L. A.; Miasoedov, N. F.; Zozulia, A. A. [Semax uye selank inhibit iyo enkephalin-inosvibisa ma enzymes kubva muserum yevanhu]]. Bioorg Khim 2001, 27 (3), 180-183. DOI: 10.1023/a:10113730028

(6) Handizive, G. G.; Teleshova, E. S.; Bochkarev, V. K.; Koschelev, V. V.; Syunyakov, T. S. P.3.036 Novel anxiolytic Selank: Migumisiro yePhase II yekiriniki miedzo. European Neuropsychopharmacology 2005, 15, S159-S160. DOI: 10.1016/s0924-977x(05)80332-3.

(7) Slominsky, P. A.; Shadrina, M. I.; Kolomin, T. A.; Stavrovskaya, A. V.; Filatova, E. V.; Andreeva, L. A.; Illarioshkin, S. N.; Myasoedov, N. F. Peptides semax uye selank inokanganisa maitiro emakonzo ane 6-OHDA induced PD-like parkinsonism.. Kusvikira Biol Sc

(8) Sollertinskaja, T. N.; Shorokhov, M. V.; Myasoedov, N. F. Iyo cerebroprotective mhedzisiro yeSemax uye Selank mumaprimates pamhando dzakasiyana dzeneurosis. International Journal yePsychophysiology 2008, 69 (3). DOI: 10.1016/j.ijpsycho.2008.05.356.

Kutevedzana:

ac-thr-lys-pro-arg-pro-gly-pro-nh2

CAS:

/

M.W:

792.94 g/mol

Kumba Search Whatsapp Services Product